Historical record - last NADAC publication: 2/3/2016
Product Information
CARDIZEM LA 360 MG TABLET is a brand product labeled by Bausch Health US LLC, priced at $6.0461 per EA under NDC 00187204990. Its NADAC has been published 20 times since Feb 3, 2016.
The High Outlier badge above means this manufacturer's average price in the Diltiazem Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
360 mg/1
Manufacturer
Bausch Health US LLCNDC
00187204990
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
2/3/2016
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021392On Market Since
12/25/2010
Pharmacological Classes
Price Statistics
The NADAC for CARDIZEM LA 360 MG TABLET has been published 20 times since Feb 3, 2016, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.0461 per EA |
|---|---|
| All-time high | $6.0461 (Jun 15, 2016) |
| All-time low | $6.0461 (Feb 3, 2016) |
| Median price | $6.0461 |
| Average price | $6.0461 |
| Largest weekly change | 0.0% (Feb 10, 2016) |
| Weeks tracked | 20 |
| Tracking since | Feb 3, 2016 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARDIZEM LA 360 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARDIZEM LA 360 MG TABLET, manufactured by Bausch Health US LLC, is $6.0461 per EA (NDC 00187204990), effective Jun 15, 2016.
How has the price of CARDIZEM LA 360 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARDIZEM LA 360 MG TABLET has held within roughly two percent of its current level. It has been tracked across 20 weekly CMS publications since Feb 3, 2016.
What are the highest and lowest recorded NADAC prices for CARDIZEM LA 360 MG TABLET?
Since Feb 3, 2016, the NADAC for CARDIZEM LA 360 MG TABLET has ranged from a low of $6.0461 (Feb 3, 2016) to a high of $6.0461 (Jun 15, 2016), with a median of $6.0461 per EA.
Are there cheaper alternatives to CARDIZEM LA 360 MG TABLET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DILTIAZEM 24HR ER 360 MG CAP, is $0.3299 per EA — about 95% below CARDIZEM LA 360 MG TABLET.
Who manufactures CARDIZEM LA 360 MG TABLET?
CARDIZEM LA 360 MG TABLET (NDC 00187204990) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification